Detection of factor V Leiden mutation in severe pre-eclamptic Hungarian women

Clinical Genetics

Volumn 53, Issue 6, 1998, Pages 478-481

  Nagy, Bálint ^a,b   Tóth, Tamás ^a   Rigó Jr , János ^a   Karádi, István ^a   Romics, László ^a   Papp, Zoltán ^a  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b NONE   (Hungary)

Author keywords

Genetics; Leiden mutation; PCR; Pre eclampsia; Pregnancy

Indexed keywords

BLOOD CLOTTING FACTOR 5;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUNGARY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

EID: 2642617790     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb02599.x     Document Type: Article

References (19)

1. McGillivray I. Pre-Eclampsia: The Hypertensive Disease of Pregnancy. London: WB Saunders, 1983.
2. Endressen JM, Lorentzen B, Henriksen T. Increased lipolytic activity and high ratio of free fatty acids to albumin in sera from women with preeclampsia leads to triglyceride accumulation in cultured endothelial cell. Am J Obstet Gynecol 1992: 167: 440-447.
3. WHO. The hypertensive disorders of pregnancy. World Health Organization Technical Report Series 758. Geneva: World Health Organization, 1987.
4. Arngrimsson R, Björnsson S, Geirsson R, Bjönsson H, Walker J, Snaedal G. Genetic and familiar predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol 1990: 97: 767-769.
5. Husby H, Roald B, Schjetlein R, Neisheim B-I, Berg K. High levels of Lp(a) lipoprotein in a family with cases of severe pre-eclampsia. Clin Genet 1996: 50: 47-49.
6. Cooper DW, Hill J, Chesley L, Bryens CI. Genetic control of susceptibility to eclampsia and miscarriage. Br J Obstet Gyneacol 1988: 95: 644-653.
7. Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens PC, von Blomberg BME, Jakobs C. Underlying disorders associated with severe early-onset pre-eclampsia. Am J Obstet Gynecol 1995: 173: 1042-1048.
8. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C. Proc Natl Acad Sci 1993: 90: 1004-1008.
9. Griffin JH, Evatt B, Wideman C, Fernandez JA. Anticoagulant protein C pathway defective in majority of thrombophilia patients. Blood 1993: 82: 1989-1993.
10. Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993: 342: 1503-1506.
11. Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994: 369: 64-67.
12. Koster T, Rosendaal FR. Activated protein C resistance in venous thrombosis. Lancet 1994: 343: 541.
13. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994: 330: 517-522.
14. Benirschke K, Kaufman P. Pathology of the Human Placenta. New York: Springer Verlag, 1995.
15. Dizon-Townson SD, Nelson ML, Easton K, Ward K. The factor Leiden may predispose women to severe pre-eclampsia. Am J Obstet Gynecol 1996: 175: 902-905.
16. Liston AW, Kilpatrick CD. Is genetic susceptibility to pre-eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br J Obstet Gynecol 1991: 98: 1079-1086.
17. American College of Obstericians and Gynecologists: Technical Bulletin No. 91. Management of Preeclampsia, February 1986.
18. Sattar N, Gaw A, Packard JC, Greer AI. Potential pathogenic roles of aberrant lipoprotein and fatty acid metabolism in pre-eclampsia. Br J Obstet Gynaecol 1996: 103: 614-620.
19. Rees CD, Cox M, Clegg BJ. World distribution of factor V Leiden. Lancet 1995: 346: 1133-1134.